NADDI Releases Third Quarter 2017 Statistics for NPLEx System

Wednesday, November 1, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Real-time, stop-sale technology remains vital tool for pharmacists and law enforcement in the fight against criminal activity

LUTHERVILLE, Md., Nov. 1, 2017 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – the

nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers to prevent and investigate diversion of medicines for illegal purposes – applauded the electronic blocking results through the third quarter of 2017 from the National Precursor Log Exchange (NPLEx). Between January 1, 2017, and September 30, 2017, NPLEx successfully blocked the illegal sale of 959,580 boxes of medicine containing pseudoephedrine (PSE), an ingredient in many common over-the-counter (OTC) cold and allergy medicines which some criminals attempt to divert to make meth. As a result, NPLEx kept 2,504,819 grams of PSE out of the hands of potential criminals.

The NPLEx system, adopted by 33 states across the country, helps retailers enforce existing laws in real-time, across state lines, and right at the pharmacy counter by blocking unlawful purchases of these medicines before they even leave the store. Law enforcement agencies can utilize the information collected by the NPLEx system, and it can also be used by prosecutors as they build cases to put drug criminals behind bars.

Across the country, over 44,000 retailers use the NPLEx system to track sales, and some states have gone further by using NPLEx to enforce a PSE sales ban on individuals previously convicted of a meth crime. In Kentucky, Oklahoma and Tennessee, similar legislation was passed in 2012, 2013 and 2014, respectively, and these states have also experienced significant declines in meth lab seizures. As of 2016, meth lab seizures declined 86 percent in Kentucky, 93 percent in Oklahoma and 85 percent in Tennessee.

"Through the third quarter of 2017, it remains abundantly clear that NPLEx is a critical tool for retailers and law enforcement in the fight to reduce meth production in the United States," said NADDI Executive Director Charlie Cichon. "Not only does NPLEx serve as a roadblock for would-be meth criminals, but it allows for law-abiding cold and allergy sufferers to maintain access to the medicines they need, without the stress of overly restrictive PSE regulations. Combined with the nationwide decline in meth labs, this data is further proof that NPLEx remains a vital resource in our efforts to reduce domestic meth production year in and year out." 

About NADDI and Public SafetyEstablished in 1989, the National Association of Drug Diversion Investigators, Inc. (NADDI) is the leading drug diversion training organization in the US, with the largest networking platform of professionals involved in the field of pharmaceutical drug diversion. The NADDI networking platform provides the opportunity to bring diverse viewpoints, education, support and resources to the individuals facing the challenges in the fight against the misuse and abuse of pharmaceutical drugs. You can learn about NADDI here:  

View original content:

SOURCE National Association of Drug Diversion Investigators


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store